The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar DisordersIsabella Pacchiarotti, Shigenobu Kanba, Ana González‐Pinto et al.|American Journal of Psychiatry|2013Cited by 754
The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disordersMauricio Tohen, Michael Berk, Ellen Frank et al.|Bipolar Disorders|2009Cited by 507
Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser <i>v.</i> mood stabiliser aloneMauricio Tohen, Joseph R. Calabrese, K. N. Roy Chengappa et al.|The British Journal of Psychiatry|2004Cited by 328
Olanzapine Versus Placebo in the Treatment of Adolescents With Bipolar ManiaMauricio Tohen, Joseph Biederman, Ludmila Kryzhanovskaya et al.|American Journal of Psychiatry|2007Cited by 316
Complex polypharmacy in bipolar disorder: Side effect burden, adherence, and response predictorsVicki Fung, Andrew A. Nierenberg, Lindsay Overhage et al.|Journal of Affective Disorders|2019Cited by 44